Rxo (RXO) Non-Current Deferred Tax Liability (2021 - 2026)

Rxo (RXO) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $36.0 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 53.25% year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.0 million (down 53.25% YoY) and the FY2025 annual result came in at $51.0 million, down 66.67% from the prior year.
• Non-Current Deferred Tax Liability retreated to $36.0 million in Q1 2026, from $51.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $153.0 million in Q4 2024 to a low of $1.0 million in Q1 2024.
• A 5-year average of $50.4 million and a median of $40.0 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability tumbled 93.75% — and 2025, when it soared 7600.0%.
• Tracing RXO's Non-Current Deferred Tax Liability over 5 years: stood at $16.0 million in 2022, then jumped by 118.75% to $35.0 million in 2023, then soared by 337.14% to $153.0 million in 2024, then slumped by 66.67% to $51.0 million in 2025, then dropped by 29.41% to $36.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $36.0 million (Q1 2026), $51.0 million (Q4 2025), and $54.0 million (Q3 2025), per Business Quant data.